• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于药物缓释的固体脂质纳米粒

The use of solid lipid nanoparticles for sustained drug release.

作者信息

Attama Anthony A, Umeyor Chukwuebuka E

机构信息

Drug Delivery & Nanomedicines Research Unit, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria.

Nanomedicine & Drug Delivery Research Unit, Department of Pharmaceutics & Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka 422001, Anambra State, Nigeria.

出版信息

Ther Deliv. 2015;6(6):669-84. doi: 10.4155/tde.15.23.

DOI:10.4155/tde.15.23
PMID:26149784
Abstract

Novel solid lipid drug delivery systems such as solid lipid nanoparticles (SLN) have attracted wide and increasing attention in recent years. It has been sought as an interesting alternative drug delivery carrier system for bioactives for a variety of delivery routes. They show major advantages such as sustained release, improved bioavailability, improved drug incorporation and very wide application. This paper presents a discussion on the production protocols of SLN, lyophilization of SLN and delivery of SLN across the blood-brain barrier. Special attention was also paid to entrapment and release of drugs from SLN and strategies to enhance drug entrapment in SLN for sustained release. Analytical methods for the characterization of SLN were also discussed. Various routes of administration of SLN were presented as well as a consideration of the ethical issues and future prospects in the production and use of SLN for sustained release of bioactives.

摘要

近年来,新型固体脂质药物递送系统,如固体脂质纳米粒(SLN),已引起广泛且日益增长的关注。它已被视作一种用于多种给药途径的生物活性物质的有趣替代药物递送载体系统。它们具有诸如缓释、提高生物利用度、改善药物包封率以及广泛应用等主要优点。本文讨论了固体脂质纳米粒的制备方案、固体脂质纳米粒的冻干以及固体脂质纳米粒跨越血脑屏障的递送。还特别关注了药物从固体脂质纳米粒中的包封和释放,以及增强药物在固体脂质纳米粒中包封以实现缓释的策略。还讨论了用于表征固体脂质纳米粒的分析方法。介绍了固体脂质纳米粒的各种给药途径,并考虑了在生产和使用固体脂质纳米粒以实现生物活性物质缓释方面的伦理问题和未来前景。

相似文献

1
The use of solid lipid nanoparticles for sustained drug release.用于药物缓释的固体脂质纳米粒
Ther Deliv. 2015;6(6):669-84. doi: 10.4155/tde.15.23.
2
Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics.一种创新的“环糊精包载氢氯噻嗪-固体脂质纳米粒”制剂的研发及其体内评价:具有缓释特性并可提高口服生物利用度,用于儿科潜在高血压治疗。
Int J Pharm. 2017 Apr 15;521(1-2):73-83. doi: 10.1016/j.ijpharm.2017.02.022. Epub 2017 Feb 14.
3
Diazepam-loaded solid lipid nanoparticles: design and characterization.载地西泮固体脂质纳米粒:设计与表征
AAPS PharmSciTech. 2009;10(1):211-9. doi: 10.1208/s12249-009-9197-2. Epub 2009 Mar 10.
4
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier.载脂蛋白 E 修饰的固体脂质纳米粒:一种穿越血脑屏障的可行策略。
J Control Release. 2017 Mar 10;249:103-110. doi: 10.1016/j.jconrel.2017.01.039. Epub 2017 Jan 31.
5
Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.药物溶解度和脂质载体对用于皮肤给药的脂质纳米粒药物释放的影响。
Eur J Pharm Biopharm. 2017 Jan;110:39-46. doi: 10.1016/j.ejpb.2016.10.021. Epub 2016 Oct 31.
6
Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.脑内递送达泊西汀的固体脂质纳米粒:制剂设计、体外与体内研究。
Int J Pharm. 2012 Dec 15;439(1-2):49-62. doi: 10.1016/j.ijpharm.2012.09.054. Epub 2012 Oct 6.
7
Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite.负载咖啡因的固体脂质纳米粒治疗橘皮组织的组织病理学评价
Drug Dev Ind Pharm. 2015;41(10):1640-6. doi: 10.3109/03639045.2014.980426. Epub 2014 Nov 10.
8
Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems.固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC)的制备、表征及物理化学性质:它们作为胶体药物载体系统的优势
Pharmazie. 2006 May;61(5):375-86.
9
Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.维生素 K1 传递用固体脂质纳米粒的特性描述和制剂优化。
Drug Dev Ind Pharm. 2010 Jul;36(7):751-61. doi: 10.3109/03639040903460453.
10
Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.固体脂质纳米粒用于口服药物传递:壳聚糖包衣改善了稳定性、控制释放、黏膜黏附性和细胞摄取。
Carbohydr Polym. 2015 May 20;122:221-9. doi: 10.1016/j.carbpol.2014.12.084. Epub 2015 Jan 13.

引用本文的文献

1
Three-Dimensionally Printed Scaffolds and Drug Delivery Systems in Treatment of Osteoporosis.用于治疗骨质疏松症的三维打印支架及药物递送系统
Biomimetics (Basel). 2025 Jul 1;10(7):429. doi: 10.3390/biomimetics10070429.
2
Mechanistic insight into the bioactivity of prodigiosin-entrapped lipid nanoparticles against triple-negative breast, lung and colon cancer cell lines.对包裹灵菌红素的脂质纳米颗粒针对三阴性乳腺癌、肺癌和结肠癌细胞系的生物活性的机制性洞察。
Heliyon. 2023 Jun 7;9(6):e16963. doi: 10.1016/j.heliyon.2023.e16963. eCollection 2023 Jun.
3
Preparation, Characterization and Pharmacokinetics of Tolfenamic Acid-Loaded Solid Lipid Nanoparticles.
托芬那酸固体脂质纳米粒的制备、表征及药代动力学
Pharmaceutics. 2022 Sep 13;14(9):1929. doi: 10.3390/pharmaceutics14091929.
4
Solid Lipid Nanoparticles for Efficient Oral Delivery of Tyrosine Kinase Inhibitors: A Nano Targeted Cancer Drug Delivery.用于高效口服递送酪氨酸激酶抑制剂的固体脂质纳米粒:一种纳米靶向癌症药物递送方法
Adv Pharm Bull. 2022 Mar;12(2):298-308. doi: 10.34172/apb.2022.041. Epub 2021 Jul 3.
5
Development, Statistical Optimization and Characterization of Fluvastatin Loaded Solid Lipid Nanoparticles: A 3 Factorial Design Approach.氟伐他汀固体脂质纳米粒的研制、统计优化及表征:一种三因素设计方法
Pharmaceutics. 2022 Mar 8;14(3):584. doi: 10.3390/pharmaceutics14030584.
6
Artemisinin-Type Drugs in Tumor Cell Death: Mechanisms, Combination Treatment with Biologics and Nanoparticle Delivery.青蒿素类药物与肿瘤细胞死亡:作用机制、与生物制剂的联合治疗及纳米颗粒递送
Pharmaceutics. 2022 Feb 10;14(2):395. doi: 10.3390/pharmaceutics14020395.
7
FbD directed fabrication and investigation of luliconazole based SLN gel for the amelioration of candidal vulvovaginitis: a 2 T (thermosensitive & transvaginal) approach.基于氟康唑的固体脂质纳米粒凝胶用于改善念珠菌性外阴阴道炎的聚焦超声介导制备与研究:一种双模式(热敏与经阴道)方法
Saudi J Biol Sci. 2021 Jan;28(1):317-326. doi: 10.1016/j.sjbs.2020.10.005. Epub 2020 Oct 16.
8
Development, in vitro and in vivo evaluations of novel lipid drug delivery system of (P. Beauv.).新型脂质药物递送系统(P. Beauv.)的开发、体外和体内评价
Nanobiomedicine (Rij). 2016 Nov 22;3:1849543516673445. doi: 10.1177/1849543516673445. eCollection 2016 Jan-Dec.
9
Antinociceptive antibiotics-loaded into solid lipid nanoparticles of prolonged release: Measuring pharmacological efficiency and time span on chronic monoarthritis rats.载有长效固体脂质纳米粒的抗伤害性抗生素:在慢性单关节炎大鼠上测量药物效力和持续时间。
PLoS One. 2018 Apr 12;13(4):e0187473. doi: 10.1371/journal.pone.0187473. eCollection 2018.
10
Overcoming clofazimine intrinsic toxicity: statistical modelling and characterization of solid lipid nanoparticles.克服氯法齐明内在毒性:固体脂质纳米粒的统计建模与特性研究。
J R Soc Interface. 2018 Feb;15(139). doi: 10.1098/rsif.2017.0932.